rs549956055
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_000426.4(LAMA2):āc.2361A>Cā(p.Lys787Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,613,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000426.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMA2 | NM_000426.4 | c.2361A>C | p.Lys787Asn | missense_variant | 17/65 | ENST00000421865.3 | NP_000417.3 | |
LAMA2 | NM_001079823.2 | c.2361A>C | p.Lys787Asn | missense_variant | 17/64 | NP_001073291.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMA2 | ENST00000421865.3 | c.2361A>C | p.Lys787Asn | missense_variant | 17/65 | 5 | NM_000426.4 | ENSP00000400365.2 | ||
LAMA2 | ENST00000618192.5 | c.2361A>C | p.Lys787Asn | missense_variant | 17/66 | 5 | ENSP00000480802.2 | |||
LAMA2 | ENST00000617695.5 | c.2361A>C | p.Lys787Asn | missense_variant | 17/64 | 5 | ENSP00000481744.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152042Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251146Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135724
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1460888Hom.: 0 Cov.: 30 AF XY: 0.0000372 AC XY: 27AN XY: 726764
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74390
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Nov 08, 2022 | The LAMA2 c.2361A>C (p.Lys787Asn) missense variant results in the substitution of lysine at amino acid position 787 with asparagine. To our knowledge, this variant has not been reported in the peer-reviewed literature. The highest frequency of this allele in the Genome Aggregation Database is 0.000326 in the East Asian population (version 2.1.1). This variant was identified in a homozygous state. Based on the available evidence, the c.2361A>C (p.Lys787Asn) variant is classified as a variant of uncertain significance for LAMA2-related muscular dystrophy. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 24, 2023 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 11, 2023 | The c.2361A>C (p.K787N) alteration is located in exon 17 (coding exon 17) of the LAMA2 gene. This alteration results from a A to C substitution at nucleotide position 2361, causing the lysine (K) at amino acid position 787 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
LAMA2-related muscular dystrophy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at